Vertex Pharmaceuticals | VRTX - Чистый доход

Биржевая цена
424.36
Изменение за день
-5.49 -1.28%
Ежемесячно
-2.29%
Ежегодный
-5.70%
Q2 прогноз
415.10




Чистый доход Изменить Дата
AbbVie USD 695M 1.12B 2026-03
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amgen USD 1.82B 486M 2026-03
Arrowhead Research USD 30.81M 54.56M 2025-12
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Gilead Sciences USD 2.18B 869M 2025-12
Incyte USD 303.33M 4.05M 2026-03
Insmed USD -328.48M 41.54M 2025-12
Ionis Pharmaceuticals USD -93M 136M 2026-03
J&J USD 5.24B 119M 2026-03
Merck USD -4.24B 7.2B 2026-03
Moderna USD -1.34B 517M 2026-03
Neurocrine Biosciences USD 153.7M 55.8M 2025-12
Novartis USD 3.16B 747M 2026-03
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR 1.61B 2.42B 2026-03
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
United Therapeutics USD 364.3M 25.6M 2025-12
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03